China Biologic Products (CBPO) News Today → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free CBPO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative December 14, 2023 | bbc.comChina hits back at Trump with tariffs on $60bn of US goodsJune 22, 2023 | marketwatch.comBiologic Excipients industry research covers a wide range of industries with predicted CAGR 10% during 2023-2030May 6, 2023 | marketwatch.comNerve Biologic Products Market 2023-2030: Future Hypothesize and ascending UpdatesApril 16, 2023 | marketwatch.comBiologic Excipients Market by 2030: Future Scope and PredictionsApril 14, 2023 | nypost.comWhat is the US’ ‘One China’ policy, and why is it important?April 9, 2023 | marketwatch.comNerve Biologic Products Market in 2023: Insights and Strategies | 2029March 8, 2023 | marketwatch.comBiologic Excipients Market New Innovations and Future Expansion 2023-2028February 19, 2023 | marketwatch.com2023 Nerve Repair and Re-generation Biologic Products Market Future Innovations, Industry Trends and Demand Forecast 2028February 14, 2023 | yahoo.comNeutropenia Biologic Drug Treatment Global Market Report 2023January 30, 2023 | marketwatch.comBiologic Imaging Reagents Market is anticipated to shown growth by 2028 |91 Report PagesJanuary 3, 2023 | yahoo.comBiologic Imaging Reagents Market will reach to USD 6.40 billion by 2030 : GreyViewsDecember 10, 2022 | marketwatch.comBiologic Injectors Market 2022 Latest Research, Top Impacting Factors, Growth Strategies and Forecast to 2028November 24, 2022 | ft.comChina bars celebrities from endorsing products to boost ‘traditional virtues’October 4, 2022 | reuters.comChina sets oil products export quotas at about 15 million tonnesSeptember 6, 2022 | marketwatch.comNerve Biologic Products market is projected to grow with magnificent CAGR| Exclusive Report Spread Across 91 PagesAugust 12, 2022 | thestreet.comBlood Money -- This Plasma Maker Is Set to SoarJuly 11, 2022 | finance.yahoo.comConnect Moves Forward CBP-201 Top-Line Results Timeline for Pivotal China Atopic Dermatitis Trial to Second Half 2022June 9, 2022 | finance.yahoo.comBiologic API CDMO Benchmarking Report 2022: Comprehensive Analysis of Current Outsourcing Trends and PracticesNovember 17, 2021 | apnews.comChina Biologic Privatization Transaction Led by Centurium Capital Wins AVCJ “Deal of the Year - Large Cap”July 27, 2021 | finance.yahoo.comWere Hedge Funds Right About Silgan Holdings Inc. (SLGN)? Get China Biologic Products News Delivered to You Automatically Sign up to receive the latest news and ratings for CBPO and its competitors with MarketBeat's FREE daily newsletter. Email Address Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election. See who it is HERE. CBPO Media Mentions By Week CBPO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CBPO News Sentiment▼0.000.76▲Average Medical News Sentiment CBPO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CBPO Articles This Week▼00▲CBPO Articles Average Week Get China Biologic Products News Delivered to You Automatically Sign up to receive the latest news and ratings for CBPO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IBRX News KRYS News CRSP News IMVT News HALO News SWTX News EXEL News ACLX News RVMD News IOVA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CBPO) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Biologic Products Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.